Assay Detail
Binding
CHEMBL5553736
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Inhibition of full length EPHA2 (unknown origin) expressed in HEK293T cells using NanoBRET NanoGlo substrate incubated for 2 hrs in presence of K4 tracer by NanoBRET assay
12
Total Activities
12
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Cell Type | HEK293T |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Back-Pocket Optimization of 2-Aminopyrimidine-Based Macrocycles Leads to Potent EPHA2/GAK Kinase Inhibitors.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 12 | 6.26 | 6.60 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5571675 | — | — | 1 | 6.60 |
| CHEMBL5568747 | — | — | 1 | 6.58 |
| CHEMBL1198514 | — | — | 1 | 6.57 |
| CHEMBL5566108 | — | — | 1 | 6.47 |
| CHEMBL5572722 | — | — | 1 | 6.43 |
| CHEMBL5595264 | — | — | 1 | 6.36 |
| CHEMBL5565547 | — | — | 1 | 6.33 |
| CHEMBL5570805 | — | — | 1 | 6.33 |
| CHEMBL5566270 | — | — | 1 | 5.85 |
| CHEMBL5574808 | — | — | 1 | 5.80 |
| CHEMBL1235529 | — | — | 1 | 5.55 |
| CHEMBL5574265 | — | — | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5571675 | — | EC50 | = | 250.0 | nM | 6.60 |
| CHEMBL5568747 | — | EC50 | = | 260.0 | nM | 6.58 |
| CHEMBL1198514 | — | EC50 | = | 270.0 | nM | 6.57 |
| CHEMBL5566108 | — | EC50 | = | 340.0 | nM | 6.47 |
| CHEMBL5572722 | — | EC50 | = | 370.0 | nM | 6.43 |
| CHEMBL5595264 | — | EC50 | = | 440.0 | nM | 6.36 |
| CHEMBL5565547 | — | EC50 | = | 470.0 | nM | 6.33 |
| CHEMBL5570805 | — | EC50 | = | 470.0 | nM | 6.33 |
| CHEMBL5566270 | — | EC50 | = | 1400.0 | nM | 5.85 |
| CHEMBL5574808 | — | EC50 | = | 1600.0 | nM | 5.80 |
| CHEMBL1235529 | — | EC50 | = | 2800.0 | nM | 5.55 |
| CHEMBL5574265 | — | EC50 | - | — | - |